<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Journal of Modern Oncology</journal-id><journal-title-group><journal-title xml:lang="en">Journal of Modern Oncology</journal-title><trans-title-group xml:lang="ru"><trans-title>Современная онкология</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1815-1434</issn><issn publication-format="electronic">1815-1442</issn><publisher><publisher-name xml:lang="en">LLC Obyedinennaya Redaktsiya</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">26430</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Farmakoekonomicheskiy analiz "stoimost'-poleznost'" kak kriteriy ekonomicheskoy obosnovannosti ispol'zovaniya byudzhetnykh sredstv v onkologii</article-title><trans-title-group xml:lang="ru"><trans-title>Фармакоэкономический анализ "стоимость-полезность" как критерий экономической обоснованности использования бюджетных средств в онкологии</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Poddubnaya</surname><given-names>I V</given-names></name><name xml:lang="ru"><surname>Поддубная</surname><given-names>И В</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кафедра онкологии РМАПО</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Arkad'eva</surname><given-names>T V</given-names></name><name xml:lang="ru"><surname>Аркадьева</surname><given-names>Т В</given-names></name></name-alternatives><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Davidenko</surname><given-names>I S</given-names></name><name xml:lang="ru"><surname>Давиденко</surname><given-names>И С</given-names></name></name-alternatives><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Rozenbaum</surname><given-names>L A</given-names></name><name xml:lang="ru"><surname>Розенбаум</surname><given-names>Л А</given-names></name></name-alternatives><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en"></institution></aff><aff><institution xml:lang="ru">РМАПО</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en"></institution></aff><aff><institution xml:lang="ru">Краснодарский городской онкологический диспансер</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2001-09-15" publication-format="electronic"><day>15</day><month>09</month><year>2001</year></pub-date><volume>3</volume><issue>3</issue><issue-title xml:lang="en">VOL 3, NO3 (2001)</issue-title><issue-title xml:lang="ru">ТОМ 3, №3 (2001)</issue-title><fpage>114</fpage><lpage>117</lpage><history><date date-type="received" iso-8601-date="2020-04-09"><day>09</day><month>04</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2001, Consilium Medicum</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2001, ООО "Консилиум Медикум"</copyright-statement><copyright-year>2001</copyright-year><copyright-holder xml:lang="en">Consilium Medicum</copyright-holder><copyright-holder xml:lang="ru">ООО "Консилиум Медикум"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://modernonco.orscience.ru/1815-1434/article/view/26430">https://modernonco.orscience.ru/1815-1434/article/view/26430</self-uri><abstract xml:lang="ru"><p>В настоящее время в онкологии, как и в других отраслях медицины, врачи должны заботиться не только об увеличении продолжительности жизни, но и об улучшении ее качества, поэтому при оценке эффективности лечения необходимо учитывать его влияние как на выживаемость, так и на качество жизни. Для этого используется метод фармакоэкономического анализа "стоимость-полезность".</p></abstract></article-meta></front><body></body><back><ref-list/></back></article>
